Ranbaxy Granted Final FDA Approval To Market Simvastatin 5, 10, 20 And 40 Mg Tablets (Medical News Today)
Ranbaxy Laboratories Limited (RLL), announced today that the Company has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market Simvastatin Tablets USP, 5 mg, 10 mg, 20 mg and 40 mg in the U.S. [click link for full article]

INVEGA(TM) Approved By FDA As New Treatment For Schizophrenia (Medical News Today)
The U.S. Food and Drug Administration (FDA) has approved INVEGA(TM) (paliperidone) Extended-Release Tablets, a new atypical antipsychotic, for the treatment of schizophrenia. [click link for full article]

Abiomed Announces FDA 510(K) Clearance for New Intra-Aortic Balloon and Development of Integrated Console, the iPulse, ... (RedNova)
Abiomed, Inc. (NASDAQ: ABMD) today announced U.S. Food and Drug Administration (FDA) clearance of its new intra-aortic balloon (IAB); an easy-to-insert, minimally invasive technology designed to enhance blood flow to the heart and other organs for patients with diminished heart function.